The All Party Parliamentary Group on Cancer's new report  'Progress of the England Cancer Strategy: Delivering outcomes by 2020?' concludes that the England Cancer Strategy risks failure unless NHS England takes corrective action.  Extensive evidence was received from across the NHS and sector, including over 80 written submission and two oral evidence sessions, including a submission from Action Bladder Cancer UK.   The report also highlights: 

Challenges facing the cancer workforce pose a significant threat to the success of the Cancer Strategy.

• Significant delays in a strategic review of the cancer workforce, which underpins the success of the strategy.
• Concern around the delays in the release of transformation funding for Cancer Alliances as well as the requirements to demonstrate an improvement in the 62-day wait standard as a prerequisite to access their transformation funding.
• There should be an increased focus on improving transparency and lines of communication.